Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Sales and Divestitures: 2025

  • Phibro Animal Health's Gains from Sales and Divestitures was N/A to $30,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $30,000, marking a year-over-year change of. This contributed to the annual value of $30,000 for FY2025, which is N/A change from last year.
  • Latest data reveals that Phibro Animal Health reported Gains from Sales and Divestitures of $30,000 as of Q2 2025, which was down 0.00% from $30,000 recorded in Q1 2025.
  • In the past 5 years, Phibro Animal Health's Gains from Sales and Divestitures ranged from a high of $30,000 in Q1 2025 and a low of $30,000 during Q1 2025.
  • Over the past 1 years, Phibro Animal Health's median Gains from Sales and Divestitures value was $30,000 (recorded in 2025), while the average stood at $30,000.